1 40 1 Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. URL Address <a href="http://doi.org/10.1080/1120009x.2002.11782351" target="_blank" rel="noreferrer noopener">http://doi.org/10.1080/1120009x.2002.11782351</a> Rights Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s). Pages 42-56 Volume 14 Search for Full-text Locate full-text within NEOMED Library's e-journal collections <p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p> Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae Publisher An entity responsible for making the resource available Journal of Chemotherapy Date A point or period of time associated with an event in the lifecycle of the resource 2002 2002-07 Subject The topic of the resource Infectious Diseases; Pathology; united-states; Pharmacology & Pharmacy; in-vitro; Oncology; community-acquired pneumonia; macrolide resistance; streptococci; respiratory; pneumoniae; haemophilus-influenzae; moraxella-catarrhalis; tract infections; macrolides; otitis-media; group-a; erythromycin resistance; decreased susceptibility; initial antimicrobial therapy; pneumococcal resistance; S.; treatment failure Creator An entity primarily responsible for making the resource Moellering R C; Consensus Working Grp Description An account of the resource Macrolide resistance among Streptococcus pneumoniae is a growing global concern, although its specific impact on public health is not currently well defined. A Consensus Working Group was convened in March 2001 to address whether credible, scientific data substantiate macrolide resistance in S. pneumoniae as: (i) producing significant morbidity; (ii) creating attendant health and economic burdens; (iii) constituting a public health threat; and (iv) warranting intervention, including development of new antibiotics with efficacy against these strains. Despite the limitations of available clinical data, concern about the possibility of treatment failure with macrolides is being expressed in clinical practice and in formal treatment guidelines, threatening the important role of these agents in the treatment of respiratory tract infections. Further studies are required to monitor and control macrolide resistance and evaluate settings in which macrolide treatment failures are occurring, and new therapeutic interventions are needed. Identifier An unambiguous reference to the resource within a given context <a href="http://doi.org/10.1080/1120009x.2002.11782351" target="_blank" rel="noreferrer noopener">10.1080/1120009x.2002.11782351</a> Format The file format, physical medium, or dimensions of the resource Journal Article or Conference Abstract Publication 2002 Community-acquired pneumonia Consensus Working Grp decreased susceptibility erythromycin resistance group-a haemophilus-influenzae in-vitro Infectious Diseases initial antimicrobial therapy Journal Article or Conference Abstract Publication Journal of Chemotherapy macrolide resistance macrolides Moellering R C moraxella-catarrhalis oncology otitis-media Pathology Pharmacology & Pharmacy pneumococcal resistance pneumoniae respiratory S. streptococci tract infections Treatment Failure united-states